SCDM CCDM試験復習赤本 & CCDM認定内容CCDM認定試験の準備をするために、CertJuken の専門家たちは彼らの豊富な知識と実践を生かして特別なトレーニング資料を研究しました。CertJuken のSCDMのCCDM問題集はあなたが楽に試験に受かることを助けます。CertJuken のSCDMのCCDM練習テストはCCDM試験問題と解答、 CCDM 問題集、CCDM 書籍やCCDM勉強ガイドに含まれています。 SCDM Certified Clinical Data Manager 認定 CCDM 試験問題 (Q35-Q40):質問 # 35
Which metrics report listed below would best help identify trends in the clinical data?
A. Number of subjects screened/enrolled
B. Last patient/last visit date to data lock date
C. Percent of data/visits cleaned
D. Query frequency counts per data element
正解：D
解説：
The Query frequency counts per data element (Option D) is the best metric for identifying data trends and potential systemic data issues in clinical trials.
According to the Good Clinical Data Management Practices (GCDMP, Chapter: Data Quality Assurance and Control), trend analysis involves identifying recurring data issues across subjects, sites, or variables to detect training gaps, protocol misinterpretation, or CRF design flaws. A high number of queries generated for specific fields (e.g., visit date, lab values, or dosing information) may indicate systemic problems such as unclear CRF instructions or site-level misunderstandings.
While metrics such as percent of data cleaned (A) and time to database lock (B) reflect overall progress and efficiency, they do not identify specific data pattern issues. The number of subjects screened/enrolled (C) pertains to recruitment rather than data quality.
Therefore, query frequency per data element provides actionable insights for quality improvement, process refinement, and early identification of potential risks.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Quality Assurance and Control, Section 6.3 - Metrics and Trend Analysis ICH E6 (R2) Good Clinical Practice, Section 5.18.4 - Risk-Based Quality Review and Data Trends FDA Guidance for Industry: Oversight of Clinical Investigations - Risk-Based Monitoring, Section 6 - Data Metrics and Trend Evaluation
質問 # 36
ePRO data are collected for a study using study devices given to subjects. Which is the most appropriate quality control method for the data?
A. Data visualizations to look for site-to-site variation
B. Programmed edit checks to detect out of range values after submission to the database
C. Manual review of data by the site study coordinator at the next visit
D. Programmed edit checks to detect out of range values upon data entry
正解：D
解説：
When electronic patient-reported outcomes (ePRO) devices are used, data are captured directly by subjects through validated devices and transmitted electronically to the study database. To ensure real-time data quality control, programmed edit checks should be implemented at the point of data entry - that is, as subjects input data into the device.
According to Good Clinical Data Management Practices (GCDMP, Chapter: Data Validation and Cleaning), front-end programmed edit checks are the optimal method to prevent entry of invalid or out-of-range values in ePRO systems. This helps maintain data accuracy at the source, minimizing downstream queries and data cleaning workload.
Options A and B involve post-submission or manual review, which is less efficient and not compliant with the principle of first-pass data validation. Option C (visualization) is a valuable secondary QC method for trends, but not for immediate data validation.
Therefore, option D is correct - programmed edit checks upon data entry ensure immediate validation and higher data integrity.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Data Validation and Cleaning, Section 5.3 - Automated Edit Checks and Front-End Validation ICH E6(R2) GCP, Section 5.5.3 - Computerized System Controls and Validation FDA Guidance for Industry: Electronic Source Data in Clinical Investigations (2013), Section 6 - Real-Time Data Quality Control
質問 # 37
A group of researchers is planning an investigator-initiated study. Assuming that SOPs are not available, which is the best approach for documentation of data management in the planned study?
A. Data handling should be documented in a data management plan
B. Data management SOPs must be developed prior to initiation of study
C. A Data Management Plan (DMP) template should be developed and a study DMP should be created
D. Data management related activities should be briefly described in the study protocol
正解：C
解説：
In the context of an investigator-initiated trial (IIT) where Standard Operating Procedures (SOPs) are not available, the most appropriate and compliant approach is to develop a Data Management Plan (DMP) template and then create a study-specific DMP based on that template (Option C).
According to the Good Clinical Data Management Practices (GCDMP, Chapter on Data Management Planning and Study Start-up), the DMP is the central document that defines all processes, responsibilities, systems, and quality controls related to data collection, processing, validation, and database management throughout the clinical study. The DMP serves as a formal framework for ensuring data integrity, traceability, and regulatory compliance, especially in the absence of established institutional SOPs.
While SOPs provide organizational-level standards, the DMP provides study-specific operational detail. In an investigator-initiated setting, researchers often lack institutional data management infrastructure, so the DMP must substitute for SOP guidance by detailing:
Data entry and validation procedures
Query management and resolution processes
CRF design and data flow specifications
Database design, backup, and security
Responsibilities of study personnel (investigator, data manager, statistician) Quality control and audit trail practices Option A ("Data handling should be documented in a DMP") is correct in principle but incomplete-without a DMP template, there is no standardized format or consistency across studies.
Option B (developing full SOPs) is not practical for a single IIT; SOPs are organizational-level documents requiring longer development and approval cycles.
Option D (briefly describing data management in the protocol) is insufficient, as the protocol should reference data management activities but not serve as the operational manual for them.
Therefore, Option C provides the most comprehensive, regulatory-compliant, and practical solution-ensuring structured documentation of all data management activities while maintaining flexibility for investigator-led research.
Reference (CCDM-Verified Sources):
Society for Clinical Data Management (SCDM), Good Clinical Data Management Practices (GCDMP), Chapter: Data Management Planning and Study Start-up, Section 5.2 - Data Management Plan (DMP) Development and Maintenance ICH E6 (R2) Good Clinical Practice, Section 5.1 - Quality Management and Documentation Requirements FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 4 - Data Management and Documentation Practices SCDM GCDMP, Chapter: Project Management in Data Management - Study-Specific Documentation and Planning in Investigator-Initiated Trials
質問 # 38
A protocol amendment adds three data elements to the vital signs screen and two additional data-collection time points. Which is best practice for handling changes to the form completion guidelines?
A. Rely on the revised CRF to enforce the changes without updating guidelines or notifying sites
B. Update the guidelines and post the new version on the trial portal
C. Notify sites of the change without a guideline update
D. Update the guidelines and notify sites of changes prior to implementing the change
正解：D
解説：
The best practice when implementing a protocol amendment that affects CRF content or data collection timing is to update the eCRF completion guidelines and notify sites before implementing the change.
According to the GCDMP (Chapter: CRF Design and Data Collection), the eCRF Completion Guidelines (eCRF CG) are an essential study tool that instructs site personnel on accurate and consistent data entry. When new data elements or collection time points are added, the guidelines must be revised, version-controlled, and communicated to all users prior to implementation to ensure sites collect and enter data correctly.
Simply relying on the revised CRF (option C) or updating the document without notification (option B) violates communication and training standards. Likewise, notifying sites without updating the documentation (option D) leaves insufficient reference material for data entry compliance.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: CRF Design and Data Collection, Section 5.5 - Managing CRF Revisions and Site Communication ICH E6 (R2) GCP, Section 5.18.4 - Communication of Protocol Amendments and Documentation Updates FDA Guidance for Industry: Electronic Source Data in Clinical Investigations, Section 4.3 - Site Communication and Documentation Management
質問 # 39
An organization is using an international data exchange standard and a new version is released. Which of the following should be assessed first?
A. Availability of other standards covering the same content
B. Content coverage of the new version
C. Existence of backwards compatibility
D. Cost of migrating to the new version
正解：C
解説：
When an updated version of a data exchange standard (such as CDISC SDTM, ADaM, or ODM) is released, the first factor that should be assessed is backwards compatibility. This determines whether the new version can interoperate with or accept data from prior versions without significant reconfiguration or data loss.
According to the Good Clinical Data Management Practices (GCDMP) and CDISC Implementation Guides, assessing backwards compatibility ensures that historical or ongoing study data remain valid and usable within the updated environment. If the new version introduces structural or semantic changes (such as variable name modifications or controlled terminology updates), it could impact mapping, validation, or regulatory submissions.
Once backward compatibility is confirmed, secondary assessments such as content coverage, availability of overlapping standards, and migration cost can be considered. However, ensuring that the new version supports existing infrastructure and data continuity is the first critical step before adoption.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Standards and Data Integration, Section 4.2 - Data Standards Updates and Compatibility Considerations CDISC SDTM Implementation Guide, Section 1.5 - Backward Compatibility and Version Control ICH E6(R2) GCP, Section 5.5 - Data Handling and Standardization